| Quantity: | |
|---|---|
【COMPOSITION AND CONTENT】
This product contains inactivated Newcastle Disease Virus Strain La Sota, Infectious Bronchitis Virus Strain M41 and H9 Subtype Avian Influenza Virus Strain SY. Before inactivation, the viral titer of Newcastle Disease Virus Strain La Sota is no less than 3×10⁸·⁰ EID₅₀ per 0.1 mL; the viral titer of Infectious Bronchitis Virus Strain M41 is no less than 3×10⁶·⁰ EID₅₀ per 0.1 mL; the viral titer of H9 Subtype Avian Influenza Virus Strain SY is no less than 3×10⁸·⁰ EID₅₀ per 0.1 mL.
【CHARACTER】
Milky white homogeneous emulsion.
【INDICATIONS】
For the prevention of Newcastle disease, infectious bronchitis and H9 subtype avian influenza in chickens. The immune duration lasts 4 months.
【DOSAGE AND ADMINISTRATION】
Administer via subcutaneous or intramuscular injection in the neck. 0.3 mL per chicken for chicks aged 2 to 4 weeks; 0.5 mL per chicken for chickens aged over 4 weeks.
【PRESENTATION】
100 mL/bottle, 250 mL/bottle
【STORAGE AND SHELF LIFE】
Store at 2–8 °C. Shelf life: 12 months from the date of manufacture.
For use only under veterinary supervision.
1. Three mainstream strain compounding for one-shot triple disease prevention: Scientifically compounded with three prevalent field strains to prevent Newcastle disease, infectious bronchitis and H9 avian influenza simultaneously. It simplifies farm immune procedures, reduces repeated vaccination stress and cuts overall epidemic prevention costs for daily flock immunization.
2. Super-high triple antigen titer ensures sufficient and powerful protection: All three antigens adopt ultra-high titer raw liquid formula with balanced and sufficient active ingredients. It rapidly activates comprehensive specific immunity, produces high and uniform antibody titers, strongly resists wild virus infection, and effectively reduces the incidence of respiratory diseases, mixed infections and egg production loss.
3. Optimized immune combination of live priming + inactivated boosting: Matching standard farm immune procedures, live vaccine priming realizes rapid mucosal defense, while this inactivated vaccine boosts and solidifies long-term humoral immunity. The dual immune system makes up for the deficiency of single live vaccine immunization and achieves more thorough and durable protection.
4. Mature full-inactivated process ensures mild temperament and zero virus diffusion risk: The thoroughly inactivated vaccine has no live virus residue or biosafety hidden dangers. It causes no adverse reactions to healthy flocks, does not affect growth and production performance, and is safe for universal immunization of broilers, layers and breeder chickens.
5. High-quality homogeneous emulsion for stable sustained-release immunity: The fine and uniform milky white emulsion features stable physical and chemical properties. The sustained-release antigen is absorbed gently after injection, continuously stimulates stable antibody production, and maintains a 4-month fixed immune period to stabilize long-term flock epidemic prevention.
Q: What type of vaccine is this? What diseases does it prevent?
A: This is a triple inactivated vaccine against Newcastle disease, infectious bronchitis and H9 subtype avian influenza. Compounded with three prevalent strains, it serves as the core basic vaccine for full-coverage daily epidemic prevention in poultry farms.
Q: What are the core advantages and protection characteristics of the vaccine?
A: The vaccine realizes three-disease prevention with one injection and simplifies immune procedures. With ultra-high triple antigen titer, optimized live+inactivated combined immunity, age-segmented dosage, high safety, stable emulsion and flexible operation, it is perfectly suitable for standardized daily epidemic prevention of various poultry farms.
Q: What are the applicable flocks, vaccination methods and standard dosages?
A: Only applicable to healthy chickens via neck subcutaneous or intramuscular injection. The dosage is 0.3mL per bird for 2–4-week-old chicks and 0.5mL per bird for chickens over 4 weeks old to ensure qualified immune effect for flocks at all stages.
Q: Why is live vaccine priming recommended before using this vaccine?
A: Live vaccine priming rapidly activates mucosal immunity as the first line of defense, while this inactivated vaccine boosts systemic humoral immunity. The combined immunization solves the problems of low and fast-decaying antibodies of single immunization and realizes dual long-term and efficient protection.
Q: What is the immune protection cycle of the vaccine?
A: The fixed immune duration is 4 months after standard vaccination for healthy flocks. Supplementary immunization can be arranged according to the growth cycle and local epidemic situation to maintain stable and efficient herd antibody levels.
